Navigation Links
Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
Date:10/15/2009

.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 43 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit their website at www.pharmanet.com. 

    Azopharma Product Development Group, LLC
    Contact: Phil Meeks
    Phone: 954-433-7480
    development@azopharma.com

    PharmaNet Development Group, Inc.
    Contact: Anne-Marie Hess
    Phone: 609-951-6842
    ahess@pharmanet.com

SOURCE PharmaNet Development Group, Inc.; Azopharma Product Development Group, LLC


'/>"/>
SOURCE PharmaNet Development Group, Inc.; Azopharma Product Development Group, LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009
2. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
3. Metabolic Solutions Development Company To Test Potential Treatment for Alzheimers
4. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)
5. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
6. Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development
7. VELOCITY Broadcasting Appoints Senior Director of Strategic Business Development
8. Catalyst Pharmaceutical Partners Continues Clinical Development of CPP-109 For The Treatment of Cocaine and Methamphetamine Addiction
9. Pres. Clinton Announces Commitment From Inter-American Development Bank, Global Network for Neglected Tropical Diseases, and Pan American Health Organization to Mobilize $30 Million to Fight NTDs in the Americas at CGI Conference
10. Michael J. Fox Foundation Commits Up to $12 Million for Targeted Parkinsons Therapeutic Development in 2010
11. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... Riverain Medical announced today t...nadian medical imaging distributor Christie Group ...rd Chest Xray CAD. The exclusive agreement will br... to the Canadian market through Christie Group,s e...View Enhanced Chest Imaging increases the clarity ...
(Date:11/19/2009)...onal Internet Week of Action ,, SILVER SPRING,...Food and Drug Administration today completed a coo...he International Internet Week of Action (IIWA), i...products. ,, (Logo: http://www.newscom.com/cgi...rt, the FDA,s Office of Criminal Investigations (O...
(Date:11/19/2009)...ional Internet Week of Action ,, SILVER SPRING...Food and Drug Administration today completed a coo...he International Internet Week of Action (IIWA), i...products. ,, (Logo: http://www.newscom.com/cg...fort, the FDA,s Office of Criminal Investigations ...
Breaking Medicine Technology:Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2FDA Issues 22 Warning Letters to Web Site Operators 2PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities 21 Organizations Supporting Those with Disabilities 48473 1PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities 21 Organizations Supporting Those with Disabilities 48473 2PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities 21 Organizations Supporting Those with Disabilities 48473 3PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities 21 Organizations Supporting Those with Disabilities 48473 4PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities 21 Organizations Supporting Those with Disabilities 48473 5PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities 21 Organizations Supporting Those with Disabilities 48473 6Specific genetic cause of fetal alcohol related developmental disorders found 8789 1Specific genetic cause of fetal alcohol related developmental disorders found 8789 2Havels Incorporated Expands Successful EchoStim 28R 29 Ultrasound Needles into Canada 48468 1Havels Incorporated Expands Successful EchoStim 28R 29 Ultrasound Needles into Canada 48468 2
...rrelate the Results of Rosetta Genomics, MicroRNA-...t M.D. Anderson Cancer Center,Data on the Company,...y and, Accuracy was Recently Published in the Apri...and JERSEY CITY, New Jersey, August 11, Rosetta Ge...pment of microRNA-based diagnostic and therapeutic...
...Y., Aug. 8 Lixte,Biotechnology Holdings, Inc. (OT...compounds from each of two different types of drug...fic types of brain cancers have,activity against h...hn S. Kovach, President and CEO of Lixte, said, "L...each of two different classes of,pharmacologic age...
Other Medicine Technology:M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases 2M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases 3M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases 4Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2
(Date:11/20/2009)...e-FirstCall/ - NUCRYST Pharmaceuticals Corp. annou...will be held on Monday, December 21, 2009. The pur... special resolutions. The first special resolution...bstantially all of the assets of NUCRYST, substant...ase agreement dated November 10, 2009 among the NU...
(Date:11/20/2009).../ -- Following a recall by Unilever The Stop &...s Country Crock ® Side Dishes DELUXE Cheddar ...e Dishes DELUXE Four Cheese Pasta due to an undecl...ates and UPCs are affected: ,, Shedd,s Country...Rice 21 oz, UPC 027400218316, Best By NOV 29 09 th...
(Date:11/20/2009)...swire/ -- The American Dental Association (ADA) to...DA) to establish appropriate classifications for t...out the safety of whitening products that are ofte... consultation or examination by a dentist, the Ass...ased tooth whitening or bleaching agents can harm ...
(Date:11/20/2009)...wswire-USNewswire/ -- Samuel Gladding is no Scroog...s to be "happy" during the holidays. As a licensed... counseling and chair of the Department of Counsel...rch shows that it is the pressure to be happy that... the holidays. ,, That,s why he,s challenging t...
(Date:11/20/2009)...n the Journal of the National Cancer Institute d...n appear in news coverage of cancer research. The ... journals to help alleviate the problem. , Lisa ..., M.S., of Center for Medicine and the Media at th...al Practice in New Hampshire, and Barnett S. Krame...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...n for Parkinson,s Research today announced the lau...f Parkinson,s Disease Therapeutics to,the Brain. T...ch addressing,two major challenges to the developm...utics to cross the blood-brain,barrier. The second...
...cer conference in Europe, it is the only one that ...he conference encourages interaction and collabora...n a partnership of equals to talk not just about s...pected to attract over 5000 delegates from around ...
...ancer Center will open a Phase I pancreatic cancer... researchers from Israel, marking the first time c... counterparts in Israel. , The study is supporte...ence Commercialization Center (VIBCC) helped to fo...
...,provider of quality control products and services...oday the launch of the first standardized External...ococcus aureas (MRSA),molecular testing. The OptiQ...lished October 2007 in the Journal of the American...
...rcent to $12.4 Billion, ARLINGTON HEIGHTS, Ill., ... and a looming home lending crisis, average,Americ...cording to the,latest procedural statistics report...ease from 2006 and a 59 percent,increase from 2000...
... , WASHINGTON, March 25 Experts on Social,Securi...plications of the,2008 Social Security and Medicar...ease. All experts listed below are members of the ..., and other programs. The Academy does,not lobby o...
Other Medicine News:Health News:Michael J. Fox Foundation Commits Up to $2 Million to Improve Drug Delivery for Parkinson's Disease 2Health News:Michael J. Fox Foundation Commits Up to $2 Million to Improve Drug Delivery for Parkinson's Disease 3Health News:An invitation to Europe's largest forum on breast cancer 2Health News:VCU Massey Cancer Center to partner with Israeli biotech firm 2Health News:VCU Massey Cancer Center to partner with Israeli biotech firm 3Health News:AcroMetrix Announces Launch of First Liquid MRSA Positive Control 2Health News:Plastic Surgery Procedures Maintain Steady Growth in 2007 2Health News:NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports 2Health News:NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports 3
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: